Reunion Neuroscience Inc.

NasdaqGS:REUN Stock Report

Market Cap: US$12.5m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Reunion Neuroscience Balance Sheet Health

Financial Health criteria checks 4/6

Reunion Neuroscience has a total shareholder equity of CA$21.3M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$29.7M and CA$8.4M respectively.

Key information

0%

Debt to equity ratio

CA$0

Debt

Interest coverage ration/a
CashCA$27.20m
EquityCA$21.30m
Total liabilitiesCA$8.44m
Total assetsCA$29.74m

Recent financial health updates

Recent updates

Reunion Neuroscience announces resignation of director, general counsel

Oct 07

Reunion Neuroscience appoints Greg Mayes as President and CEO

Sep 28

Field Trip Health  GAAP EPS of -C$0.09

Aug 15

Field Trip Health receives final court approval for clinics business spin-out

Jun 29

Financial Position Analysis

Short Term Liabilities: REUN's short term assets (CA$29.7M) exceed its short term liabilities (CA$8.4M).

Long Term Liabilities: REUN has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: REUN is debt free.

Reducing Debt: REUN had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: REUN has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: REUN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 48.9% each year


Discover healthy companies